Hint mode is switched on Switch off
For swift navigation between sections

Organization: Amgen
LEI 62QBXGPJ34PQ72Z12S66

Organization name
Amgen, Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Bond debt
38,105 mln USD

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access

Latest data on

Profile

Amgen Inc. is an American multinational biopharmaceutical company headquartered in California. Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Awards

Documentation

Stocks

Latest issues

Bond debt by currency

Codes

  • LEI
    62QBXGPJ34PQ72Z12S66
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • ICB
    4,500 Health Care
  • CIK
    0000318154

Credit ratings

Macroeconomic Indicators - Amgen

Registration is required to get access.